![(1R,4R)-2-(4-tolylsulfonyl)-5-(phenylmethyl)-2,5-diazabicyclo[2.2.1]heptane结构式](https://www.chemsrc.com/caspic/359/118354-72-6.png)
(1R,4R)-2-(4-tolylsulfonyl)-5-(phenylmethyl)-2,5-diazabicyclo[2.2.1]heptane结构式
|
常用名 | (1R,4R)-2-(4-tolylsulfonyl)-5-(phenylmethyl)-2,5-diazabicyclo[2.2.1]heptane | 英文名 | (1R,4R)-2-(4-tolylsulfonyl)-5-(phenylmethyl)-2,5-diazabicyclo[2.2.1]heptane |
|---|---|---|---|---|
| CAS号 | 118354-72-6 | 分子量 | 342.45500 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C19H22N2O2S | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | (1R,4R)-2-(4-tolylsulfonyl)-5-(phenylmethyl)-2,5-diazabicyclo[2.2.1]heptane |
|---|---|
| 英文别名 | 更多 |
| 分子式 | C19H22N2O2S |
|---|---|
| 分子量 | 342.45500 |
| 精确质量 | 342.14000 |
| PSA | 49.00000 |
| LogP | 3.59900 |
|
~91%
(1R,4R)-2-(4-to... 118354-72-6 |
| 文献：Bouzard, D.; Di Cesare, P.; Essiz, M.; Jacquet, J. P.; Kiechel, J. R.; et al. Journal of Medicinal Chemistry, 1990 , vol. 33, # 5 p. 1344 - 1352 |
|
~%
(1R,4R)-2-(4-to... 118354-72-6 |
| 文献：Bouzard, D.; Di Cesare, P.; Essiz, M.; Jacquet, J. P.; Kiechel, J. R.; et al. Journal of Medicinal Chemistry, 1990 , vol. 33, # 5 p. 1344 - 1352 |
|
~%
(1R,4R)-2-(4-to... 118354-72-6 |
| 文献：Bouzard, D.; Di Cesare, P.; Essiz, M.; Jacquet, J. P.; Kiechel, J. R.; et al. Journal of Medicinal Chemistry, 1990 , vol. 33, # 5 p. 1344 - 1352 |
| .1R,4R-2-(4-TOLUENESULFONYL)-5-PHENYLMETHYL-2,5-DIAZABICYCLO-(2.2.1)HEPTANE |
| .5-diazabicyclo[2.2.1]heptane |
| (1R,4R)-2-(4-toluenesulfonyl)-5-phenylmethyl-2 |
![(3S,5R)-1-[(4-methylphenyl)sulfonyl]-3-[(4-methylphenyl)sulfonyloxy]-5-[(4-methylphenyl)sulfonyloxymethyl]pyrrolidine结构式](https://www.chemsrc.com/caspic/467/116143-09-0.png)
![4-(acetyloxy)-1-[(4-methylphenyl)sulfonyl]-D-proline ethyl ester结构式](https://www.chemsrc.com/caspic/091/116143-06-7.png)
![allo-1-(4-tolylsulfonyl)-4-[[(4-methylphenyl)sulfonyl]oxy]-D-proline ethyl ester结构式](https://www.chemsrc.com/caspic/129/116143-05-6.png)
![(1S,4S)-(+)-2-苄基-2,5-二氮杂双环[2.2.1]庚烷二氢溴酸盐结构式](https://www.chemsrc.com/caspic/111/116258-17-4.png)
CAS号116258-17-4